FEN did decrease fasting hyperglycaemia and markedly attenuated glucose intolerance in Leprdb mice (Fig. 2b,c), in association with increased serum insulin (Fig. 2d) and increased pancreatic islet mass (Fig. 2e). Here, INS is linked to Glucose intolerance.